MANAGEMENT OF VENOUS SYSTEM DISEASES DURING THE PANDEMIC PERIOD

Abstract

Venous insufficiency and deep vein thrombosis (DVT) are the main venous system diseases. Although deep vein thrombosis (DVT) can lead to serious complications and even death, it is a treatable disease. Today, both DVT and pulmonary embolism (PE) are referred to by the common name of venous thromboembolism (VTE). Although COVID-19 mainly affects the respiratory system, it also tends to damage many organs and develop VTE due to its prothrombotic course. In patients recovering from COVID-19, the venous system is adversely affected due to the prothrombotic course of the disease and immobility. In our study, venous system diseases and their treatments after COVID-19 disease were reviewed. Thirty of the patients who applied to our hospital with the preliminary diagnosis of venous insufficiency after recovering from COVID-19 were included in our study. The physical examination findings and laboratory parameters of the patients were retrospectively reviewed. In all cases, besides routine laboratory tests, radiological and vascular Doppler ultrasonographic examinations were also performed. Of the 30 patients included in the study, 11 (36.6%) were male and 19 (63.3%) were female. Their ages ranged from 30 to 79 years, with a mean age of 59.4±12.77 years. Venous insufficiency was detected in all patients in venous Doppler ultrasonographic examination. In addition, DVT was also detected in four cases. Fifteen (50%) of our patients were hypertensive. Diabetes mellitus was also present in five of the hypertensive patients. Combined diosmin and hesperidin treatment may be preferred in cases of venous insufficiency developing after COVID-19. Since no adverse effects of warfarin have been observed in severe COVID-19 disease, it can be used safely in DVT cases that develop after the treatment of COVID19.